Aspect Partners »

Karyopharm Therapeutics shares owned by Aspect Partners

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Aspect Partners from 13F filings

Historical chart of Aspect Partners investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Aspect Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Aspect Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9k 391 7.36

More positions owned by Aspect Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares Core Msci Eafe Etf Etf (IEFA)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Spdr Gold Shares Etf (GLD)
Ishares Russell 2000 Etf Etf (IWM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares International Treasury Bond Etf Etf (IGOV)
Return Stacked Global Stocks & Bonds Etf Etf (RSSB)
Ishares Core S&p Small Cap Etf Etf (IJR)
Invesco Optimum Yield Diversified Commodity Strategy No K-1 Etf Etf (PDBC)
Ishares Gold Trust Etf (IAU)
State Street Real Estate Select Sector Spdr Etf Etf (XLRE)
Distillate Small/mid Cash Flow Etf Etf (DSMC)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)

View all positions for Aspect Partners

Top funds holding Karyopharm Therapeutics

T. Rowe Price Investment Management
Opaleye Management
Affinity Asset Advisors
Susquehanna International
Vanguard Group
Ikarian Capital
Soleus Capital Management
Adage Capital Partners GP
Davidson Kempner Capital Management
Braidwell
Exome Asset Management
Ameriprise Financial
Boxer Capital Management
BlackRock
Geode Capital Management

View all funds holding Karyopharm Therapeutics